Glucagon-like peptide-1 receptor agonists as a disease-modifying therapy for knee osteoarthritis mediated by weight loss: findings from the Shanghai Osteoarthritis Cohort

OBJECTIVE: Obesity is a risk factor for knee osteoarthritis (KOA) development and progression. Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are indicated for type 2 diabetes mellitus (T2DM) and obesity. However, whether KOA patients can benefit from GLP-1RA therapies has not been sufficientl...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Hongyi, Zhou, Lenian, Wang, Qiuke, Cai, Qianying, Yang, Fan, Jin, Hanqiang, Chen, Yiwei, Song, Yanyan, Zhang, Changqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Osteoarthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423473/
https://www.ncbi.nlm.nih.gov/pubmed/37258065
http://dx.doi.org/10.1136/ard-2023-223845

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423473/
https://www.ncbi.nlm.nih.gov/pubmed/37258065
http://dx.doi.org/10.1136/ard-2023-223845

Ejemplares similares